Share Price and Basic Stock Data
Last Updated: January 23, 2026, 8:31 pm
| PEG Ratio | 21.22 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Chembond Chemicals Ltd operates in the specialty chemicals sector, which has shown resilience amid fluctuating market conditions. For the fiscal year ending March 2023, the company reported sales of ₹440 Cr, a notable increase from ₹349 Cr in the previous fiscal year. This upward trajectory reflects a consistent growth strategy, as seen in the quarterly sales figures, which peaked at ₹122.03 Cr in March 2023. However, subsequent quarters have shown volatility, with sales declining to ₹112.02 Cr in September 2023 before slightly recovering to ₹114.60 Cr in December 2023. The trailing twelve months (TTM) revenue stands at ₹221 Cr, suggesting a potential stabilization in the company’s revenue stream. Chembond’s ability to adapt to market dynamics, such as raw material price fluctuations, will be crucial as it navigates through these changes. Overall, the company’s robust sales performance aligns with broader trends within the specialty chemicals industry, which is typically characterized by steady demand and innovation-driven growth.
Profitability and Efficiency Metrics
Chembond Chemicals Ltd reported a net profit of ₹25 Cr for the fiscal year ending March 2023, up from ₹14 Cr in the prior year, indicating improved profitability. The operating profit margin (OPM) stood at 8% for FY 2023, which reflects a recovery from the previous year’s margin of 5%. Despite fluctuations in quarterly performance, the OPM climbed to 12.95% in September 2023, suggesting effective cost management and operational efficiency. The interest coverage ratio (ICR) is exceptionally high at 71.55x, indicating that the company comfortably meets its interest obligations, a sign of financial health. Return on equity (ROE) is reported at 10.5%, while return on capital employed (ROCE) stands at 11.5%, both of which are relatively strong for the specialty chemicals sector. However, the operating profit fell to ₹7 Cr in FY 2024, which may raise concerns about sustaining profitability in the face of rising costs and market competition.
Balance Sheet Strength and Financial Ratios
Chembond Chemicals maintains a robust balance sheet with total assets recorded at ₹202 Cr as of March 2025. The company’s reserves have grown to ₹155 Cr, indicating a solid capital base for future investments. The borrowings are notably low at ₹6 Cr, reflecting prudent financial management and minimal reliance on debt financing. The current ratio stands at 4.81x, significantly higher than the typical sector benchmark, showcasing strong liquidity and the ability to cover short-term liabilities. Additionally, the company’s book value per share has increased to ₹64.77, up from ₹53.13, suggesting enhanced shareholder value. The cash conversion cycle is notably efficient at 15 days, indicating effective inventory and receivables management. These factors collectively underscore Chembond’s financial stability, although the declining trend in profitability metrics raises questions about long-term sustainability amid potential economic pressures.
Shareholding Pattern and Investor Confidence
As of March 2025, Chembond Chemicals has a stable shareholding structure, with promoters holding 67.65% of the equity, reinforcing management control and commitment to the company’s strategic direction. Foreign institutional investors (FIIs) constitute a minor stake at 0.61%, whereas domestic institutional investors (DIIs) hold 0.74%. The public shareholding stands at 31%, indicating a diversified investor base. The number of shareholders increased to 13,168 by September 2025, suggesting growing interest and confidence from retail investors. However, the minimal institutional investment might reflect caution regarding the company’s performance and market conditions. The stability among promoters and the gradual increase in public participation indicate a positive sentiment, although the low percentage of institutional ownership may limit broader market validation of the stock.
Outlook, Risks, and Final Insight
Looking ahead, Chembond Chemicals faces both opportunities and challenges. The specialty chemicals sector is poised for growth, driven by increasing demand in sectors such as pharmaceuticals and agrochemicals. However, the company must navigate risks such as fluctuating raw material costs and potential regulatory changes that could impact operational efficiency. Additionally, the declining net profit in recent quarters raises concerns about maintaining profitability and market competitiveness. Chembond’s strong balance sheet and high interest coverage provide a foundation for resilience, but ongoing vigilance in cost management and innovation is essential. Should the company successfully leverage its strengths while mitigating risks, it could emerge as a stronger player in the specialty chemicals landscape, capitalizing on industry growth trends and expanding its market share.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 345 Cr. | 37.5 | 71.7/36.8 | 21.4 | 20.5 | 1.07 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 28.0 Cr. | 57.0 | 88.8/55.0 | 13.4 | 89.6 | 1.75 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 44.5 Cr. | 655 | 899/600 | 20.5 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,221 Cr. | 71.0 | 111/68.2 | 21.3 | 22.0 | 0.70 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 547 Cr. | 219 | 377/213 | 19.6 | 93.8 | 1.14 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,127.48 Cr | 644.51 | 58.17 | 182.97 | 0.47% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 110.14 | 110.62 | 122.03 | 113.54 | 112.02 | 114.60 | 47.09 | 46.27 | 49.78 | 53.05 | 52.21 | 57.68 | 57.75 |
| Expenses | 100.93 | 99.46 | 108.81 | 104.59 | 97.51 | 100.44 | 44.01 | 42.83 | 47.01 | 49.27 | 48.61 | 54.21 | 53.73 |
| Operating Profit | 9.21 | 11.16 | 13.22 | 8.95 | 14.51 | 14.16 | 3.08 | 3.44 | 2.77 | 3.78 | 3.60 | 3.47 | 4.02 |
| OPM % | 8.36% | 10.09% | 10.83% | 7.88% | 12.95% | 12.36% | 6.54% | 7.43% | 5.56% | 7.13% | 6.90% | 6.02% | 6.96% |
| Other Income | 1.10 | 1.46 | 1.67 | 3.01 | 9.31 | 3.59 | 0.89 | 2.09 | 5.16 | 0.19 | 1.72 | 2.65 | 0.13 |
| Interest | 0.19 | 0.21 | 0.50 | 0.26 | 0.46 | 0.32 | 0.20 | 0.16 | 0.16 | 0.18 | 0.14 | 0.07 | 0.10 |
| Depreciation | 1.08 | 1.07 | 1.31 | 1.06 | 1.47 | 1.38 | 0.88 | 0.57 | 0.69 | 0.68 | 0.70 | 0.68 | 1.20 |
| Profit before tax | 9.04 | 11.34 | 13.08 | 10.64 | 21.89 | 16.05 | 2.89 | 4.80 | 7.08 | 3.11 | 4.48 | 5.37 | 2.85 |
| Tax % | 14.05% | 26.72% | 22.48% | 17.39% | 29.79% | 16.01% | 47.75% | 2.29% | 11.16% | -4.18% | 25.22% | 25.70% | -34.39% |
| Net Profit | 7.77 | 8.25 | 10.19 | 8.78 | 15.35 | 13.49 | 1.51 | 4.68 | 6.29 | 3.24 | 3.36 | 3.99 | 3.83 |
| EPS in Rs | 5.77 | 6.16 | 7.61 | 6.54 | 11.52 | 10.07 | 1.13 | 3.49 | 4.69 | 2.42 | 2.51 | 2.98 | 2.86 |
Last Updated: January 2, 2026, 2:59 am
Below is a detailed analysis of the quarterly data for Chembond Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 57.75 Cr.. The value appears strong and on an upward trend. It has increased from 57.68 Cr. (Jun 2025) to 57.75 Cr., marking an increase of 0.07 Cr..
- For Expenses, as of Sep 2025, the value is 53.73 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 54.21 Cr. (Jun 2025) to 53.73 Cr., marking a decrease of 0.48 Cr..
- For Operating Profit, as of Sep 2025, the value is 4.02 Cr.. The value appears strong and on an upward trend. It has increased from 3.47 Cr. (Jun 2025) to 4.02 Cr., marking an increase of 0.55 Cr..
- For OPM %, as of Sep 2025, the value is 6.96%. The value appears strong and on an upward trend. It has increased from 6.02% (Jun 2025) to 6.96%, marking an increase of 0.94%.
- For Other Income, as of Sep 2025, the value is 0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 2.65 Cr. (Jun 2025) to 0.13 Cr., marking a decrease of 2.52 Cr..
- For Interest, as of Sep 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.07 Cr. (Jun 2025) to 0.10 Cr., marking an increase of 0.03 Cr..
- For Depreciation, as of Sep 2025, the value is 1.20 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.68 Cr. (Jun 2025) to 1.20 Cr., marking an increase of 0.52 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.85 Cr.. The value appears to be declining and may need further review. It has decreased from 5.37 Cr. (Jun 2025) to 2.85 Cr., marking a decrease of 2.52 Cr..
- For Tax %, as of Sep 2025, the value is -34.39%. The value appears to be improving (decreasing) as expected. It has decreased from 25.70% (Jun 2025) to -34.39%, marking a decrease of 60.09%.
- For Net Profit, as of Sep 2025, the value is 3.83 Cr.. The value appears to be declining and may need further review. It has decreased from 3.99 Cr. (Jun 2025) to 3.83 Cr., marking a decrease of 0.16 Cr..
- For EPS in Rs, as of Sep 2025, the value is 2.86. The value appears to be declining and may need further review. It has decreased from 2.98 (Jun 2025) to 2.86, marking a decrease of 0.12.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274 | 299 | 270 | 291 | 327 | 301 | 268 | 274 | 349 | 440 | 178 | 201 | 221 |
| Expenses | 253 | 273 | 259 | 274 | 304 | 275 | 258 | 256 | 332 | 405 | 172 | 188 | 206 |
| Operating Profit | 21 | 26 | 11 | 17 | 23 | 26 | 10 | 18 | 17 | 35 | 7 | 14 | 15 |
| OPM % | 8% | 9% | 4% | 6% | 7% | 8% | 4% | 7% | 5% | 8% | 4% | 7% | 7% |
| Other Income | 1 | 1 | 189 | 18 | 11 | 4 | 3 | 15 | 9 | 5 | 14 | 9 | 5 |
| Interest | 4 | 4 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| Depreciation | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 4 | 5 | 3 | 3 | 3 |
| Profit before tax | 15 | 20 | 195 | 30 | 28 | 24 | 8 | 29 | 21 | 34 | 17 | 19 | 16 |
| Tax % | 40% | 28% | 20% | 24% | 16% | 19% | 61% | 28% | 32% | 26% | 33% | 10% | |
| Net Profit | 9 | 14 | 156 | 23 | 24 | 20 | 3 | 20 | 14 | 25 | 11 | 18 | 14 |
| EPS in Rs | 5.76 | 9.24 | 114.66 | 14.43 | 16.40 | 12.93 | 1.40 | 15.18 | 10.39 | 18.73 | 8.34 | 13.10 | 10.77 |
| Dividend Payout % | 26% | 16% | 4% | 11% | 11% | 16% | 144% | 15% | 48% | 16% | 42% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 55.56% | 1014.29% | -85.26% | 4.35% | -16.67% | -85.00% | 566.67% | -30.00% | 78.57% | -56.00% | 63.64% |
| Change in YoY Net Profit Growth (%) | 0.00% | 958.73% | -1099.54% | 89.60% | -21.01% | -68.33% | 651.67% | -596.67% | 108.57% | -134.57% | 119.64% |
Chembond Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -6% |
| 3 Years: | -17% |
| TTM: | -10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 54% |
| 3 Years: | 4% |
| TTM: | -34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 8% |
| 3 Years: | 7% |
| 1 Year: | -62% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 7% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 1:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:06 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 80 | 89 | 200 | 223 | 242 | 255 | 262 | 286 | 297 | 315 | 137 | 149 | 155 |
| Borrowings | 33 | 25 | 11 | 9 | 9 | 7 | 3 | 2 | 2 | 7 | 7 | 3 | 6 |
| Other Liabilities | 86 | 83 | 72 | 82 | 68 | 54 | 50 | 59 | 56 | 74 | 41 | 43 | 44 |
| Total Liabilities | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 191 | 202 | 211 |
| Fixed Assets | 54 | 51 | 47 | 49 | 108 | 109 | 124 | 122 | 121 | 116 | 26 | 34 | 41 |
| CWIP | 3 | 3 | 2 | 2 | 1 | 2 | 0 | 0 | 1 | 12 | 13 | 8 | 1 |
| Investments | 1 | 1 | 88 | 150 | 76 | 58 | 51 | 73 | 75 | 65 | 65 | 78 | 68 |
| Other Assets | 148 | 147 | 152 | 120 | 140 | 153 | 147 | 160 | 165 | 208 | 87 | 83 | 101 |
| Total Assets | 205 | 203 | 289 | 321 | 325 | 322 | 322 | 354 | 361 | 402 | 191 | 202 | 211 |
Below is a detailed analysis of the balance sheet data for Chembond Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Reserves, as of Sep 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 149.00 Cr. (Mar 2025) to 155.00 Cr., marking an increase of 6.00 Cr..
- For Borrowings, as of Sep 2025, the value is 6.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 3.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 3.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 44.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 43.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 1.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 211.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 202.00 Cr. (Mar 2025) to 211.00 Cr., marking an increase of 9.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 34.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 8.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 78.00 Cr. (Mar 2025) to 68.00 Cr., marking a decrease of 10.00 Cr..
- For Other Assets, as of Sep 2025, the value is 101.00 Cr.. The value appears strong and on an upward trend. It has increased from 83.00 Cr. (Mar 2025) to 101.00 Cr., marking an increase of 18.00 Cr..
- For Total Assets, as of Sep 2025, the value is 211.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2025) to 211.00 Cr., marking an increase of 9.00 Cr..
Notably, the Reserves (155.00 Cr.) exceed the Borrowings (6.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -12.00 | 1.00 | 0.00 | 8.00 | 14.00 | 19.00 | 7.00 | 16.00 | 15.00 | 28.00 | 0.00 | 11.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 116 | 105 | 78 | 84 | 90 | 110 | 112 | 111 | 94 | 96 | 100 | 72 |
| Inventory Days | 74 | 60 | 46 | 59 | 46 | 58 | 77 | 82 | 67 | 53 | 58 | 56 |
| Days Payable | 113 | 96 | 86 | 95 | 96 | 84 | 96 | 120 | 76 | 81 | 118 | 113 |
| Cash Conversion Cycle | 77 | 70 | 38 | 49 | 40 | 84 | 94 | 73 | 84 | 67 | 40 | 15 |
| Working Capital Days | 53 | 45 | 90 | 42 | 44 | 82 | 98 | 83 | 78 | 70 | 39 | 25 |
| ROCE % | 15% | 18% | 22% | 12% | 11% | 9% | 3% | 10% | 7% | 10% | 5% | 12% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 |
|---|---|---|
| FaceValue | 5.00 | 5.00 |
| Basic EPS (Rs.) | 11.54 | 11.20 |
| Diluted EPS (Rs.) | 11.54 | 11.20 |
| Cash EPS (Rs.) | 13.33 | 12.13 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 64.77 | 53.13 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 64.77 | 53.13 |
| Revenue From Operations / Share (Rs.) | 108.67 | 105.31 |
| PBDIT / Share (Rs.) | 17.76 | 16.97 |
| PBIT / Share (Rs.) | 15.93 | 16.00 |
| PBT / Share (Rs.) | 15.68 | 15.78 |
| Net Profit / Share (Rs.) | 11.49 | 11.16 |
| NP After MI And SOA / Share (Rs.) | 11.54 | 11.20 |
| PBDIT Margin (%) | 16.34 | 16.11 |
| PBIT Margin (%) | 14.65 | 15.19 |
| PBT Margin (%) | 14.42 | 14.98 |
| Net Profit Margin (%) | 10.57 | 10.59 |
| NP After MI And SOA Margin (%) | 10.62 | 10.63 |
| Return on Networth / Equity (%) | 17.81 | 21.07 |
| Return on Capital Employeed (%) | 24.05 | 29.22 |
| Return On Assets (%) | 14.36 | 16.50 |
| Asset Turnover Ratio (%) | 1.47 | 0.00 |
| Current Ratio (X) | 4.81 | 4.32 |
| Quick Ratio (X) | 4.33 | 3.83 |
| Inventory Turnover Ratio (X) | 16.42 | 0.00 |
| Interest Coverage Ratio (X) | 71.55 | 76.92 |
| Interest Coverage Ratio (Post Tax) (X) | 47.31 | 51.58 |
After reviewing the key financial ratios for Chembond Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 12.13 (Mar 24) to 13.33, marking an increase of 1.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.77. It has increased from 53.13 (Mar 24) to 64.77, marking an increase of 11.64.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 64.77. It has increased from 53.13 (Mar 24) to 64.77, marking an increase of 11.64.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 108.67. It has increased from 105.31 (Mar 24) to 108.67, marking an increase of 3.36.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 17.76. This value is within the healthy range. It has increased from 16.97 (Mar 24) to 17.76, marking an increase of 0.79.
- For PBIT / Share (Rs.), as of Mar 25, the value is 15.93. This value is within the healthy range. It has decreased from 16.00 (Mar 24) to 15.93, marking a decrease of 0.07.
- For PBT / Share (Rs.), as of Mar 25, the value is 15.68. This value is within the healthy range. It has decreased from 15.78 (Mar 24) to 15.68, marking a decrease of 0.10.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.49. This value is within the healthy range. It has increased from 11.16 (Mar 24) to 11.49, marking an increase of 0.33.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.54. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 11.54, marking an increase of 0.34.
- For PBDIT Margin (%), as of Mar 25, the value is 16.34. This value is within the healthy range. It has increased from 16.11 (Mar 24) to 16.34, marking an increase of 0.23.
- For PBIT Margin (%), as of Mar 25, the value is 14.65. This value is within the healthy range. It has decreased from 15.19 (Mar 24) to 14.65, marking a decrease of 0.54.
- For PBT Margin (%), as of Mar 25, the value is 14.42. This value is within the healthy range. It has decreased from 14.98 (Mar 24) to 14.42, marking a decrease of 0.56.
- For Net Profit Margin (%), as of Mar 25, the value is 10.57. This value exceeds the healthy maximum of 10. It has decreased from 10.59 (Mar 24) to 10.57, marking a decrease of 0.02.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.62. This value is within the healthy range. It has decreased from 10.63 (Mar 24) to 10.62, marking a decrease of 0.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 17.81, marking a decrease of 3.26.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.05. This value is within the healthy range. It has decreased from 29.22 (Mar 24) to 24.05, marking a decrease of 5.17.
- For Return On Assets (%), as of Mar 25, the value is 14.36. This value is within the healthy range. It has decreased from 16.50 (Mar 24) to 14.36, marking a decrease of 2.14.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.47. It has increased from 0.00 (Mar 24) to 1.47, marking an increase of 1.47.
- For Current Ratio (X), as of Mar 25, the value is 4.81. This value exceeds the healthy maximum of 3. It has increased from 4.32 (Mar 24) to 4.81, marking an increase of 0.49.
- For Quick Ratio (X), as of Mar 25, the value is 4.33. This value exceeds the healthy maximum of 2. It has increased from 3.83 (Mar 24) to 4.33, marking an increase of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 16.42. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 16.42, marking an increase of 16.42.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 71.55. This value is within the healthy range. It has decreased from 76.92 (Mar 24) to 71.55, marking a decrease of 5.37.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 47.31. This value is within the healthy range. It has decreased from 51.58 (Mar 24) to 47.31, marking a decrease of 4.27.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Chembond Chemicals Ltd:
- Net Profit Margin: 10.57%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.05% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.81% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 47.31
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.33
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.3 (Industry average Stock P/E: 58.17)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.57%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Chembond Centre, EL71, MIDC Mahape, New Mumbai Maharashtra 400710 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sameer V Shah | Chairman & Managing Director |
| Mr. Nirmal V Shah | Non Executive Director |
| Mr. Jayesh P Shah | Independent Director |
| Mrs. Gorsi A Parekh | Independent Director |
| Mr. Jaywant K Tawade | Additional Executive Director |
| Mr. Kamal Tandon | Addnl.Independent Director |
| Mr. Mayank P Shah | Independent Director |
FAQ
What is the intrinsic value of Chembond Chemicals Ltd?
Chembond Chemicals Ltd's intrinsic value (as of 24 January 2026) is ₹158.40 which is 2.19% higher the current market price of ₹155.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹209 Cr. market cap, FY2025-2026 high/low of ₹490/136, reserves of ₹155 Cr, and liabilities of ₹211 Cr.
What is the Market Cap of Chembond Chemicals Ltd?
The Market Cap of Chembond Chemicals Ltd is 209 Cr..
What is the current Stock Price of Chembond Chemicals Ltd as on 24 January 2026?
The current stock price of Chembond Chemicals Ltd as on 24 January 2026 is ₹155.
What is the High / Low of Chembond Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Chembond Chemicals Ltd stocks is ₹490/136.
What is the Stock P/E of Chembond Chemicals Ltd?
The Stock P/E of Chembond Chemicals Ltd is 15.3.
What is the Book Value of Chembond Chemicals Ltd?
The Book Value of Chembond Chemicals Ltd is 121.
What is the Dividend Yield of Chembond Chemicals Ltd?
The Dividend Yield of Chembond Chemicals Ltd is 1.13 %.
What is the ROCE of Chembond Chemicals Ltd?
The ROCE of Chembond Chemicals Ltd is 11.5 %.
What is the ROE of Chembond Chemicals Ltd?
The ROE of Chembond Chemicals Ltd is 10.5 %.
What is the Face Value of Chembond Chemicals Ltd?
The Face Value of Chembond Chemicals Ltd is 5.00.